cilostazol has been researched along with Shock, Septic in 1 studies
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol did not enhance intracellular cyclic AMP (cAMP) levels." | 5.36 | Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms. ( Choi, IW; Choi, JS; Choi, YH; Jung, WK; Kim, GY; Lee, DY; Moon, C; Park, C; Park, SG; Park, WS; Seo, SK; Yea, SS, 2010) |
| "Cilostazol did not enhance intracellular cyclic AMP (cAMP) levels." | 1.36 | Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms. ( Choi, IW; Choi, JS; Choi, YH; Jung, WK; Kim, GY; Lee, DY; Moon, C; Park, C; Park, SG; Park, WS; Seo, SK; Yea, SS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, WS | 1 |
| Jung, WK | 1 |
| Lee, DY | 1 |
| Moon, C | 1 |
| Yea, SS | 1 |
| Park, SG | 1 |
| Seo, SK | 1 |
| Park, C | 1 |
| Choi, YH | 1 |
| Kim, GY | 1 |
| Choi, JS | 1 |
| Choi, IW | 1 |
1 other study available for cilostazol and Shock, Septic
| Article | Year |
|---|---|
Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cilostazol; Cyclic AMP; Cytokines; Female; Inflammation Mediators | 2010 |